Shengli Meng 孟胜利

Deputy Director, Wuhan Institute of Biological Products, Research Centre, Sinopharm Group


Mr. Shengli Meng was Doctor of Immunology at Wuhan Institute of Biological Products from 2004-2010.  From 2010 to now, he has been the Deputy Director of Wuhan Institute of Biological Products.


He participated in the development of "2019-NCOV inactivated vaccine”.  Publications include articles and books for international and domestic magazines.


Mr. Meng is also an editorial board member of international Journal of Biological Products; evaluation expert of Wuhan Science and Technology Bureau; expert of Chinese biological quality management; and has more than 10 years of experience in virus and vaccine related research. He is also familiar with the development progress and technical path of domestic vaccine.



重点研究成果:参与开发 “2019-nCov灭活疫苗”




Copyright © 2020 Nomura

This website is the sole property of Nomura. No part of this website may be reproduced in any form of by any means - electronic, mechanical, photocopying, recording or otherwise - without the prior written permission of Nomura.